Founded in 2011, with personalized diagnosis and treatment of cardiovascular, tumor as the strategic direction, Wuhan YZY Medical Science and Technology Co., Ltd. (YZY MED) is a high-tech enterprise specializing in the R&D, production and sales of individualized medical diagnostic products. The company has established various technical platforms, including ARMS fluorescence qPCR, multiple fluorescence qPCR, fluorescence in situ hybridization (FISH) and circulating tumor cell detection, etc. Meanwhile, the self-developed products include molecular diagnostic products to guide personalized medicine for cardiovascular and cerebrovascular diseases, companion diagnostic products to guide tumor diagnosis and treatment, FISH products and circulating tumor cell (CTC) autoanalyzer system, all these provide clinical diagnosis basis for precision medicine. With a R&D center of 2,000㎡and GMP-accredited industrialized workshop of 3,200㎡,YZY MED has successfully developed over 160 genetic diagnostic products and multiple in vitro diagnostic (IVD) devices, among which nearly 20 molecular diagnostic kits have been approved by the NMPA Class III medical device registration and approval, more than 110 products have passed the CE certification.